Home

Qualigen Therapeutics, Inc. - Common Stock (QLGN)

3.3000
-0.1500 (-4.35%)

Qualigen Therapeutics Inc is a biotechnology company focused on developing and commercializing innovative therapies and diagnostics for various medical conditions

Its primary mission is to enhance healthcare solutions through its proprietary technologies, particularly in the fields of oncology and infectious diseases. The company offers a range of products, including its advanced diagnostic platforms that aim to facilitate quicker and more accurate disease detection, as well as therapeutic candidates designed to improve treatment outcomes for patients facing serious health challenges. Through its cutting-edge research and development efforts, Qualigen seeks to contribute to the future of personalized medicine and improve the quality of life for patients worldwide.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Qualigen Therapeutics, Inc. - Common Stock publicly traded?
Yes, Qualigen Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Qualigen Therapeutics, Inc. - Common Stock trade on?
Qualigen Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Qualigen Therapeutics, Inc. - Common Stock?
The ticker symbol for Qualigen Therapeutics, Inc. - Common Stock is QLGN on the Nasdaq Stock Market
What is the current price of Qualigen Therapeutics, Inc. - Common Stock?
The current price of Qualigen Therapeutics, Inc. - Common Stock is 3.300
When was Qualigen Therapeutics, Inc. - Common Stock last traded?
The last trade of Qualigen Therapeutics, Inc. - Common Stock was at 12:51 pm EST on February 5th, 2025